2-Hydroxyethyl Methacrylate (HEMA) Market Projected to Reach New Heights by 2030 Driven by Biomedical and Coating Applications

Global 2-Hydroxyethyl Methacrylate (HEMA) Market Projected to Reach New Heights by 2030 Driven by Biomedical and Coating Applications

Dec. 10, 2025 -- HDIN Research, a leading market research firm, has released its latest comprehensive analysis on the Global 2-Hydroxyethyl Methacrylate (HEMA) Market. The report highlights steady growth trajectories for this critical functional monomer, driven by increasing demand in high-performance coatings, optical resins, and medical applications.

According to the latest data from HDIN Research, the global market size for 2-Hydroxyethyl Methacrylate (HEMA) in 2025 is valued between 250 million and 500 million USD. Looking ahead, the market is expected to expand at a Compound Annual Growth Rate (CAGR) of 2.4% to 4.4% through 2030.

Understanding HEMA and Its Applications
2-Hydroxyethyl Methacrylate (CAS No. 868-77-9), commonly abbreviated as HEMA, is a versatile functional monomer. It is widely utilized in the production of coatings, inks, photo-curing materials, contact lenses, and biomedical devices. Its quality and purity are pivotal, directly influencing the performance characteristics of downstream products, including coating hardness, curing speed, and biocompatibility.

In the biomedical sector, high-purity HEMA serves as a core raw material for intraocular lenses (artificial crystals) and dental composite resins, where safety and material stability are paramount.

Competitive Landscape and Capacity Developments
The market is characterized by a mix of established global chemical giants and emerging manufacturers expanding their production capabilities. Key players include Dow, Evonik, Mitsubishi Chemical, and Wanhua Chemical Group.

Recent industry developments indicate a trend toward capacity expansion and product specialization. For instance, in May 2025, Wanhua Chemical Group announced a plan to construct a new production line with an annual capacity of 20,000 tons. This project, with a total investment of 39.61 million RMB, features a switchable production capability for HEMA and HPMA and is scheduled to commence construction in June 2026. This adds to their existing capacity of 35,000 tons.

Other significant market movements include Lotte MCC, a joint venture established in 2006 between Lotte Chemical and Mitsubishi Chemical, which maintains a substantial capacity of 11,000 tons. In the high-purity segment, companies like Evonik and Mitsubishi Chemical continue to lead with specialized product lines such as VISIOMER UHP HEMA and Acrylic Ester HISS, respectively, catering to the stringent requirements of the optical and medical industries.

Market Segmentation
The report segments the HEMA market based on application, reflecting the diverse utility of the monomer:

1. Coatings
2. Adhesives & Inks
3. Optical Resins (Contact lenses, Intraocular lenses)
4. Medical (Dental composites, Hydrogels)
5. Others

As the demand for high-performance and biocompatible materials rises, particularly in the medical and optical sectors, manufacturers are focusing on improving purity levels and optimizing production costs. HDIN Research predicts that the Asia-Pacific region will continue to be a major manufacturing hub, while demand for premium-grade HEMA will see robust growth in North America and Europe.

About HDIN Research
HDIN Research is a premier market research and consulting firm providing in-depth analysis and data-driven insights to help businesses make informed decisions. We specialize in chemical, material, and industrial markets, offering comprehensive reports that cover market size, competitive landscape, and future trends.

Media Contact
Company Name: HDIN Research
Website: www.hdinresearch.com
Email: sales@hdinresearch.com